Inventor
BOURQUE ELYSE MARIE JOSEE
CA24 patents
⚠️ This page may combine multiple inventors who share the name “BOURQUE ELYSE MARIE JOSEE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIAL—R&D INVEST S A
8 patentsUS11091492B2Aug 17, 2021
Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A5 citations83
US11932645B2Mar 19, 2024
Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A2 citations72
US11453675B2Sep 27, 2022
Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
BIAL—R&D INVEST S A2 citations72
US11400095B2Aug 2, 2022
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A2 citations72
US11351173B2Jun 7, 2022
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A3 citations72
US11168087B2Nov 9, 2021
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders
BIAL—R&D INVEST S A4 citations72
US12116369B2Oct 15, 2024
Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators
BIAL—R&D INVEST S A0 citations62
US11878979B2Jan 23, 2024
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders
BIAL—R&D INVEST S A1 citations62
LYSOSOMAL THERAPEUTICS INC
6 patentsUS10570135B2Feb 25, 2020
Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC13 citations93
US9868742B2Jan 16, 2018
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b] pyridazines, related compounds, and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC17 citations93
US9920061B2Mar 20, 2018
Imidazo[1,5-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC16 citations92
US9840510B1Dec 12, 2017
Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC16 citations92
US10751341B2Aug 25, 2020
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC12 citations85
US10786508B2Sep 29, 2020
Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC10 citations83
X4 PHARMACEUTICALS INC
5 patentsUS10759796B2Sep 1, 2020
CXCR4 inhibitors and uses thereof
X4 PHARMACEUTICALS INC6 citations83
US11306088B2Apr 19, 2022
CXCR4 inhibitors and uses thereof
X4 PHARMACEUTICALS INC2 citations72
US11780837B2Oct 10, 2023
CXCR4 inhibitors and uses thereof
X4 PHARMACEUTICALS INC0 citations62
US10988465B2Apr 27, 2021
CXCR4 inhibitors and uses thereof
X4 PHARMACEUTICALS INC1 citations62
US11332470B2May 17, 2022
CXCR4 inhibitors and uses thereof
X4 PHARMACEUTICALS INC0 citations51
BIAL—BIOTECH INVEST INC
3 patentsUS10934298B2Mar 2, 2021
Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disorders
BIAL—BIOTECH INVEST INC10 citations84
US11192892B2Dec 7, 2021
Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disorders
BIAL—BIOTECH INVEST INC4 citations72
US11124516B2Sep 21, 2021
Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
BIAL—BIOTECH INVEST INC4 citations72